Your browser doesn't support javascript.
loading
The Impact of Midodrine Tapering Versus Nontapering Regimens on the Clinical Outcomes of Critically Ill Patients: A Retrospective Cohort Study.
Gramish, Jawaher; Hattan, Ahmed; Aljuhani, Ohoud; Parameaswari, P J; Alshehri, Shaden; Korayem, Ghazwa B; Alkofide, Hadeel; Alalawi, Mai; Vishwakarma, Ramesh; Alsowaida, Yazed Saleh; Alqahtani, Rahaf; Binorayir, Luluh; Abutaleb, Mohammed; Alotaibi, Alanoud; Aljohani, Majidah; Aljohani, Sarah; Samreen, Sana; Jawhari, Suad; Alanazi, Raghad; Al Sulaiman, Khalid A.
Afiliação
  • Gramish J; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Hattan A; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Aljuhani O; King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Parameaswari PJ; Pharmaceutical Care Services, King Abdullah bin Abdulaziz University Hospital, Riyadh, Saudi Arabia.
  • Alshehri S; Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Korayem GB; Research Support Department, Research and Innovation Center, King Saud Medical City, Ministry of Health, Riyadh, Saudi Arabia.
  • Alkofide H; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Alalawi M; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Vishwakarma R; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Alsowaida YS; Department of Pharmaceutical Sciences, Fakeeh College for Medical Sciences, Jeddah, Saudi Arabia.
  • Alqahtani R; Norwich Medical School, University of East Anglia, Norwich, UK.
  • Binorayir L; Department of Clinical Pharmacy, College of Pharmacy, Hail University, Hail, Saudi Arabia.
  • Abutaleb M; Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
  • Alotaibi A; King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Aljohani M; College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Aljohani S; Pharmaceutical Care Services, King Fahad Central Hospital, Jazan Health, Jazan, Saudi Arabia.
  • Samreen S; Department of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Jawhari S; Pharmaceutical Care Division, King Saud Medical City, Riyadh, Saudi Arabia.
  • Alanazi R; Pharmaceutical Care Services, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
  • Al Sulaiman KA; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Ann Pharmacother ; 58(3): 223-233, 2024 Mar.
Article em En | MEDLINE | ID: mdl-37248667
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Midodrina Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Midodrina Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article